Skip to main content
user-generated· price

Pharma stocks rise within 6 months of stable FDA leadership

Industry leaders claim stability at the FDA would reduce uncertainty, potentially boosting investor confidence in large pharma stocks. The sector has faced volatility due to regulatory unpredictability in recent months.

price · Prediction Market

Implied probability (Yes)
65%

More price markets

Browse all price markets →

Loading…